We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Levrett | LVRT | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.50 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.50 | 3.50 |
| Top Posts |
|---|
Posted at 31/8/2017 15:48 by maytrees The time limit is a year I think jd. There would be an RNS upon delisting if that is the way it goes.Bear in mind the RNS as recently as April 2017: "Levrett, a Company formed to acquire a target company with realisable or developed commercial technologies in the pharmaceutical and biotechnology sector, announces that it has entered into a Convertible Loan Agreement for £200,000 ("Loan") with a private investor. The Loan is for a fixed term of 12 months and carries interest at 9% per annum, which the Lender can elect to convert. The Loan is convertible into new Ordinary Shares in the Company at a price of 4 pence per share ("Conversion"), and following Conversion the Lender will be granted a one-for-one warrant to subscribe for new ordinary shares at 4 pence per share, exercisable for a period of three years from Conversion. Under the terms of the Loan, the Lender will advance the total sum to the Company within three business days. The proceeds from the Loan are to be used for general working capital and to support Nuformix Limited in the short-term pending completion of the potential reverse takeover as announced by the Company on 16 September 2016. The acquisition remains conditional, inter alia, on consent from the UK Listing Authority for the readmission of the combined entity to the Standard List." Even if they do de-list all may not be lost. Last time I tried telephoning though getting through to someone who knew about issues was impossible so I am reluctant to try again. A call is unlikely to make any difference especially as there are only a couple of weeks now to announce the RTO etc or delist - either way an RNS soon in any event. |
Posted at 07/6/2017 14:03 by jimduggen Frustrating wait my friend.8 months and counting and very little regard for private investors feelings |
Posted at 20/4/2017 11:29 by maytrees Greetings FredYou may be right of course as AIM cos all seem to me to be risky but I fail to see anything in it for the private investor who has just put £200k into the company, if you are correct. I hope for something better than you predict but all imho so dyor! |
Posted at 20/4/2017 09:01 by maytrees Good morningGreat RNS imho just out reading: Levrett, a Company formed to acquire a target company with realisable or developed commercial technologies in the pharmaceutical and biotechnology sector, announces that it has entered into a Convertible Loan Agreement for £200,000 ("Loan") with a private investor. The Loan is for a fixed term of 12 months and carries interest at 9% per annum, which the Lender can elect to convert. The Loan is convertible into new Ordinary Shares in the Company at a price of 4 pence per share ("Conversion"), and following Conversion the Lender will be granted a one-for-one warrant to subscribe for new ordinary shares at 4 pence per share, exercisable for a period of three years from Conversion. Under the terms of the Loan, the Lender will advance the total sum to the Company within three business days. The proceeds from the Loan are to be used for general working capital and to support Nuformix Limited in the short-term pending completion of the potential reverse takeover as announced by the Company on 16 September 2016. The acquisition remains conditional, inter alia, on consent from the UK Listing Authority for the readmission of the combined entity to the Standard List. The 4p per share conversion price signifies some decent profit for those holding before the suspension and the whole RNS seems +ve though not certain about the RTO going ahead which presumably after all this time it would hardly be if talks were being halted. |
Posted at 11/3/2017 13:44 by maytrees Greetings jimdugganAssuming that the RTO takes place, my expectation is that the existing no of LVRT shares will be increased substantially but with current LVRT shareholders benefiting from the new shares in proportion to their current holdings. Hopefully the value of the new shares will mean that existing LVRT shareholders see gains from the RTO but given that the new shares will be traded on AIM, there can be no guarantees about share price until trading commences and prospective new investors have been able to consider the prospectus and other info on the new co. Presumably the new co will have an new name and its shares a new EPIC. All the above is subject to the RTO going ahead and is imho! |
Posted at 21/1/2017 19:37 by olufemisudem With such a small initial free float, one can expect a high admission price on return to keep the minion investors at bay.Good luck |
Posted at 02/1/2017 20:31 by olufemisudem No problem getting an institutional investor to stump up the cash. |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
